设为首页 加入收藏

TOP

RIFAFOUR®e-275 TABLETS(四)
2013-07-10 18:30:33 来源: 作者: 【 】 浏览:4132次 评论:0
inamide:
Pyrazinamide may decrease the efficacy of gout therapy (e.g. allopurinol, colchicine, probenecid or sulphinpyrazone) and dosage adjustments of this medication may be necessary.
Ethambutol:
Concurrent administration of neurotoxic medication with ethambutol may potentiate neurotoxic effects such as optic and peripheral neuritis.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
For symptoms of overdosage, refer to "Side-Effects".
Treatment of overdosage consists of gastric lavage, symptomatic and supportive therapy.

IDENTIFICATION:
Purple, round, film coated tablets.

PRESENTATION:
Securitainers of 40, 60, 80, 100 and 500 tablets.

STORAGE INSTRUCTIONS:
Store in a cool place, below 25°C in well-closed containers, protected from light.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
34/20.2.3/0187

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Aventis Pharma (Pty) Ltd
2 Bond Street, Midrand, 1685

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
11 February 2002

Aventis Pharma (Pty) Ltd
2 Bond Street
Midrand
1685

        RO2-A0003
        Britepak

New addition to this site: April 2005
Source: Hospital Pharmacy  

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 1 2 3 4 下一页 尾页 4/4/4
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇PARAPLATINE 10 mg/ml Solution p.. 下一篇DOPACARD 50 mg/5 ml Solution in..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位